Institutional Perspectives in Cancer - Hematologic Malignancies: Chaired by Catherine Coombs, MD
Institutional Perspectives in Cancer - Hematologic Malignancies: Chaired by Catherine Coombs, MD
Stay updated with breaking news from Catherine Coombs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Institutional Perspectives in Cancer - Hematologic Malignancies: Chaired by Catherine Coombs, MD
Catherine Coombs, MD discusses the present CLL front-line treatment landscape, addressing considerations like choosing fixed-duration or continuous therapy and variations in first-line approaches based on age and ECOG status.
Catherine C. Coombs, MD, and Alexey Danilov, MD, PhD, moderate a discussion on the role and sequencing of BTK inhibitors, venetoclax-based regimens, and CAR T-cell therapy in mantle cell lymphoma and chronic lymphocytic leukemia.
Early indications that it could be used to guide the length of fixed-duration therapy